Results

1–10 of 14 results for medicare

Changes in Retinal Disease Treatment Patterns Due to Copay Assistance Loss A Real-World Multi-Indication Analysis Using Vestrum Retinal Health Database
Ghassan Ghorayeb, MD
Annual Meeting Talks
2025
The Impact of Good Days' Underfunding on Retinal Disease Management Insights From a National Survey of American Society of Retina Specialists Members
Michael M. Lai, MD, PhD
Annual Meeting Talks
2025
Analysis of Antivascular Endothelial Growth Factor Utilization Trends and Prescriber Characteristics Based on Medicare Part B Claims Data: 2017-2022
Stephanie B Engelhard, MD
Annual Meeting Talks
2025
Retinal Procedure Volume and Inflation-Adjusted Medicare Reimbursement in the 21st Century
Ron A. Adelman, MD, MPH, MBA
Annual Meeting Talks
2025
Economic Impact of Anti-Vascular Endothelial Growth Factor Prior Authorization Process
Ella H Leung, MD
Annual Meeting Talks
2025
Accuracy of Initial Anti-VEGF Treatment Selection in Newly Diagnosed Neovascular Age-Related Macular Degeneration: Retina Specialist Choice vs Step Therapy
Prithvi Reddy Bomdica, MD, MBA
Annual Meeting Talks
2025
Inflation-Adjusted Trends in Medicare Reimbursement for Retina Practice Expenses
Philip I Niles, MD, MBA
Annual Meeting Talks
2023
2024 Washington Update
Michael M. Lai, MD, PhD
Updates from the Field
2024
Trends in Medicare Reimbursement for Common Vitreoretinal Procedures: 2011-2020
Shriji Patel, MD, MBA
Annual Meeting Talks
2021
Treatment Patterns and Visual and Health Function in Neovascular Age-Related Macular Degeneration (nAMD): Medicare Current Beneficiary Survey Analysis
Ferhina S Ali, MD, MPH
Annual Meeting Talks
2021